Logo image of KG

KESTREL GROUP (KG) Stock Fundamental Analysis

USA - NASDAQ:KG - BMG5260K1027 - Common Stock

27.2 USD
+0.95 (+3.62%)
Last: 9/12/2025, 8:00:02 PM
Fundamental Rating

0

Taking everything into account, KG scores 0 out of 10 in our fundamental rating. KG was compared to 146 industry peers in the Insurance industry. Both the profitability and financial health of KG have multiple concerns. KG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

KG had negative earnings in the past year.
In the past year KG has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: KG reported negative net income in multiple years.
In the past 5 years KG always reported negative operating cash flow.
KG Yearly Net Income VS EBIT VS OCF VS FCFKG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

With a Return On Assets value of -11.31%, KG is not doing good in the industry: 95.21% of the companies in the same industry are doing better.
With a Return On Equity value of -87.40%, KG is not doing good in the industry: 94.52% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -11.31%
ROE -87.4%
ROIC N/A
ROA(3y)-4.94%
ROA(5y)-1.43%
ROE(3y)-146.93%
ROE(5y)-79.11%
ROIC(3y)N/A
ROIC(5y)N/A
KG Yearly ROA, ROE, ROICKG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for KG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KG Yearly Profit, Operating, Gross MarginsKG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

More info and screens

0

2. Health

2.1 Basic Checks

KG has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, KG has more shares outstanding
Compared to 1 year ago, KG has a worse debt to assets ratio.
KG Yearly Shares OutstandingKG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
KG Yearly Total Debt VS Total AssetsKG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

KG has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
KG has a worse Debt to Equity ratio (1.16) than 90.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
KG Yearly LT Debt VS Equity VS FCFKG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
KG Yearly Current Assets VS Current LiabilitesKG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

KG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -290.26%.
Looking at the last year, KG shows a very negative growth in Revenue. The Revenue has decreased by -61.65% in the last year.
Measured over the past years, KG shows a very negative growth in Revenue. The Revenue has been decreasing by -37.29% on average per year.
EPS 1Y (TTM)-290.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%857.79%
Revenue 1Y (TTM)-61.65%
Revenue growth 3Y-17.22%
Revenue growth 5Y-37.29%
Sales Q2Q%-78.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KG Yearly Revenue VS EstimatesKG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
KG Yearly EPS VS EstimatesKG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 0 20 -20 -40 -60 -80 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

KG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KG Price Earnings VS Forward Price EarningsKG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KG Per share dataKG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

KG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KESTREL GROUP

NASDAQ:KG (9/12/2025, 8:00:02 PM)

27.2

+0.95 (+3.62%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-15 2025-08-15
Earnings (Next)11-10 2025-11-10
Inst Owners422.62%
Inst Owner Change86039900%
Ins Owners134.48%
Ins Owner Change9.69%
Market Cap210.53M
Analysts40
Price TargetN/A
Short Float %N/A
Short Ratio2.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.64
P/FCF N/A
P/OCF N/A
P/B 1.4
P/tB 1.52
EV/EBITDA N/A
EPS(TTM)-25.41
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-9.41
FCFYN/A
OCF(TTM)-9.41
OCFYN/A
SpS4.1
BVpS19.39
TBVpS17.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.31%
ROE -87.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.94%
ROA(5y)-1.43%
ROE(3y)-146.93%
ROE(5y)-79.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-290.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%857.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-61.65%
Revenue growth 3Y-17.22%
Revenue growth 5Y-37.29%
Sales Q2Q%-78.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-417.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.35%
OCF growth 3YN/A
OCF growth 5YN/A